Niklas Münchmeier

Niklas Münchmeier currently serves as the Therapeutic Area Head Oncology at Ipsen, a position held since March 2023. Prior experience includes various roles at Novartis from July 2014 to February 2023, where responsibilities ranged from Medical Head to Medical Advisor in Oncology and Cell & Gene Therapy, as well as Market Access Manager. Previous to this, Niklas held research positions as a Research Associate/Post-Doc at Scripps Research and as a Visiting Scientist at HelmholtzZentrum München. Academic background includes a role as a Research Associate and PhD student at Ludwig-Maximilians Universität München from November 2007 to February 2012.